Our Blog Melanoma360

Featured image for “Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma”
06/15/2021

Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma

June 14, 2021 08:03 AM Eastern Daylight Time  | Source: Business Wire DURHAM, N.C.–(BUSINESS WIRE)–Istari Oncology, Inc., a clinical-stage biotechnology…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “I’ve Been Diagnosed With Skin Cancer. Now What?”
06/04/2021

I’ve Been Diagnosed With Skin Cancer. Now What?

You receive a phone call from your doctor that your biopsy results are back—it’s skin cancer. Now what? First of…
Blog - Melanoma360
Featured image for “Alkermes’s disappointment hones melanoma niche focus”
06/04/2021

Alkermes’s disappointment hones melanoma niche focus

June 04, 2021  | Source: Madeleine Armstrong, Evaluate Vantage Alkermes plays up responses in mucosal melanoma, but those hoping for…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Melanoma at ASCO 2021 Annual Meeting”
06/04/2021

Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Melanoma at ASCO 2021 Annual Meeting

June 04, 2021 09:08 ET | Source: Iovance Biotherapeutics, Inc. 86% Overall Response Rate (ORR) and 43% Complete Response Rate in Immune…
Blog - Melanoma360
, 
Breaking News
Featured image for “How Tennis Star Naomi Osaka is Helping People of Color Protect Their Skin”
05/28/2021

How Tennis Star Naomi Osaka is Helping People of Color Protect Their Skin

We’re proud to partner with Mediaplanet on the recently published Skin Health campaign, out today! Skin diseases affect as many…
Blog - Melanoma360
, 
Breaking News
Featured image for “A Letter From Our Vice President | May 2021”
05/26/2021

A Letter From Our Vice President | May 2021

From the Desk of Alicia Rowell, Vice President Last Friday, May 21st,  was a sobering day for all of us…
Blog - Melanoma360
, 
Philanthropy
Featured image for “SCERF: What it is and Why You Need to Know About it”
05/26/2021

SCERF: What it is and Why You Need to Know About it

By Alicia Rowell, Vice President SCERF. It’s short for the Skin Cancer Education and Research Foundation, but we always call…
Blog - Melanoma360
Featured image for “Survivor Profile: Karlee Steele, Stage IIIB Survivor”
05/26/2021

Survivor Profile: Karlee Steele, Stage IIIB Survivor

By Alicia Rowell, Vice President A silent killer. That’s how melanoma was once described to Karlee Steele, and the silent…
Blog - Melanoma360
, 
Survivor Stories
Featured image for “Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma”
05/21/2021

Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma

PRINCETON, N.J.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced new six-and-a-half-year data from CheckMate -067, a randomized, double-blind, Phase 3…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “A Melanoma Story of Sisters, Love, and Healing”
05/12/2021

A Melanoma Story of Sisters, Love, and Healing

By Vallerie A. Malkin In her mind and heart, Alice Klunck’s sister will always be a teenager. Alice was just…
Blog - Melanoma360
, 
Friends, Family, & Caregivers
06/15/2021

Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma

June 14, 2021 08:03 AM Eastern Daylight Time  | Source: Business Wire DURHAM, N.C.–(BUSINESS WIRE)–Istari Oncology, Inc., a clinical-stage biotechnology…
Featured image for “Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
06/04/2021

I’ve Been Diagnosed With Skin Cancer. Now What?

You receive a phone call from your doctor that your biopsy results are back—it’s skin cancer. Now what? First of…
Featured image for “I’ve Been Diagnosed With Skin Cancer. Now What?”
Blog - Melanoma360
06/04/2021

Alkermes’s disappointment hones melanoma niche focus

June 04, 2021  | Source: Madeleine Armstrong, Evaluate Vantage Alkermes plays up responses in mucosal melanoma, but those hoping for…
Featured image for “Alkermes’s disappointment hones melanoma niche focus”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
06/04/2021

Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Melanoma at ASCO 2021 Annual Meeting

June 04, 2021 09:08 ET | Source: Iovance Biotherapeutics, Inc. 86% Overall Response Rate (ORR) and 43% Complete Response Rate in Immune…
Featured image for “Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Melanoma at ASCO 2021 Annual Meeting”
Blog - Melanoma360
 | 
Breaking News
05/28/2021

How Tennis Star Naomi Osaka is Helping People of Color Protect Their Skin

We’re proud to partner with Mediaplanet on the recently published Skin Health campaign, out today! Skin diseases affect as many…
Featured image for “How Tennis Star Naomi Osaka is Helping People of Color Protect Their Skin”
Blog - Melanoma360
 | 
Breaking News
05/26/2021

A Letter From Our Vice President | May 2021

From the Desk of Alicia Rowell, Vice President Last Friday, May 21st,  was a sobering day for all of us…
Featured image for “A Letter From Our Vice President | May 2021”
Blog - Melanoma360
 | 
Philanthropy
05/26/2021

SCERF: What it is and Why You Need to Know About it

By Alicia Rowell, Vice President SCERF. It’s short for the Skin Cancer Education and Research Foundation, but we always call…
Featured image for “SCERF: What it is and Why You Need to Know About it”
Blog - Melanoma360
05/26/2021

Survivor Profile: Karlee Steele, Stage IIIB Survivor

By Alicia Rowell, Vice President A silent killer. That’s how melanoma was once described to Karlee Steele, and the silent…
Featured image for “Survivor Profile: Karlee Steele, Stage IIIB Survivor”
Blog - Melanoma360
 | 
Survivor Stories
05/21/2021

Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma

PRINCETON, N.J.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced new six-and-a-half-year data from CheckMate -067, a randomized, double-blind, Phase 3…
Featured image for “Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
05/12/2021

A Melanoma Story of Sisters, Love, and Healing

By Vallerie A. Malkin In her mind and heart, Alice Klunck’s sister will always be a teenager. Alice was just…
Featured image for “A Melanoma Story of Sisters, Love, and Healing”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers

Recent Posts

Featured image for “Navigating Melanoma Together: 2024 Podcast Wrap-Up”
Dec. 12, 2024

Navigating Melanoma Together: 2024 Podcast Wrap-Up

Featured image for “Beyond the Clinic’s New Host: Introducing Dr. Sam Siegel”
Dec. 10, 2024

Beyond the Clinic’s New Host: Introducing Dr. Sam Siegel

Featured image for “Managing Melanoma During the Holiday Season”
Dec. 09, 2024

Managing Melanoma During the Holiday Season

Featured image for “Beyond the Clinic’s New Host: Dr. Sam Siegel Brings a Fresh Voice to Survivorship”
Dec. 05, 2024

Beyond the Clinic’s New Host: Dr. Sam Siegel Brings a Fresh Voice to Survivorship

Featured image for “Receiving a Heart Increases Melanoma Risk”
Dec. 03, 2024

Receiving a Heart Increases Melanoma Risk

Filter by Tag